Pseudomonas aeruginosa : a Survey of Resistance in 136 Hospitals in Spain
- 1 April 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (4) , 981-982
- https://doi.org/10.1128/aac.43.4.981
Abstract
We carried out a nationwide study with all of the isolates ofPseudomonas aeruginosa collected in a week in 136 hospitals in Spain. The data on 1,014 isolates included resistance to the following antimicrobials: piperacillin-tazobactam, 7%; meropenem, 8%; amikacin, 9%; tobramycin, 10%; piperacillin, 10%; ticarcillin, 13%; imipenem, 14%; ceftazidime, 15%; cefepime, 17%; ciprofloxacin, 23%; aztreonam, 23%; ofloxacin, 30%; gentamicin, 31%. The most frequent serotypes were O:1 (25.1%), O:4 (21.6%), and O:11 (11.3%).Keywords
This publication has 11 references indexed in Scilit:
- Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group.1998
- Emergence of Multidrug Resistance in Ubiquitous and Dominant Pseudomonas aeruginosa Serogroup O:11Journal of Clinical Microbiology, 1998
- Antibiotic resistance in Pseudomonas aeruginosa: an Italian surveyJournal of Antimicrobial Chemotherapy, 1998
- [Prevalence of serotype 0:12 among strains of P. aeruginosa causing nosocomial infection in Spain (1980-1991)].1993
- Predominant pathogens in hospital infectionsJournal of Antimicrobial Chemotherapy, 1992
- Uptake of minocycline by Escherichia coliJournal of Antimicrobial Chemotherapy, 1992
- Multiresistant serotype O 12Pseudomonas aeruginosa: evidence for a common strain in EuropeEpidemiology and Infection, 1989
- Epidemiological typing ofPseudomonas aeruginosaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988